BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16:26-42. [PMID: 29422795 DOI: 10.5217/ir.2018.16.1.26] [Cited by in Crossref: 128] [Cited by in F6Publishing: 123] [Article Influence: 32.0] [Reference Citation Analysis]
Number Citing Articles
1 Yamazaki H, Matsuoka K, Fernandez J, Hibi T, Watanabe M, Hisamatsu T, Fukuhara S. Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network). BMJ Open 2019;9:e030134. [PMID: 31501121 DOI: 10.1136/bmjopen-2019-030134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Iida T, Yokoyama Y, Wagatsuma K, Hirayama D, Nakase H. Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease. Cells. 2018;8. [PMID: 30583538 DOI: 10.3390/cells8010007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
3 Tarasiuk A, Eibl G. Nutritional Support and Probiotics as a Potential Treatment of IBD. Curr Drug Targets 2020;21:1417-27. [PMID: 32364071 DOI: 10.2174/1389450121666200504075519] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hosseini-Asl SK, Mehrabani D, Karimi-Busheri F. Therapeutic Effect of Mesenchymal Stem Cells in Ulcerative Colitis: A Review on Achievements and Challenges. J Clin Med 2020;9:E3922. [PMID: 33287220 DOI: 10.3390/jcm9123922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Vardavas AI, Porter AL. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicol Rep 2021;8:1616-37. [PMID: 34485092 DOI: 10.1016/j.toxrep.2021.08.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wibowo S, Subandiyah K, Handono K, Poeranto S. Role of vitamin D in Wnt pathway activation for colonic epithelial cell differentiation. J Taibah Univ Med Sci 2021;16:575-81. [PMID: 34408615 DOI: 10.1016/j.jtumed.2021.01.012] [Reference Citation Analysis]
7 Cheon SY, Lee JE. Extracellular Vesicles and Immune System in Ageing and Immune Diseases. Exp Neurobiol 2021;30:32-47. [PMID: 33632983 DOI: 10.5607/en20059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Masnadi Shirazi K, Nikniaz Z, Masnadi Shirazi A, Rohani M. Vitamin A supplementation decreases disease activity index in patients with ulcerative colitis: A randomized controlled clinical trial. Complementary Therapies in Medicine 2018;41:215-9. [DOI: 10.1016/j.ctim.2018.09.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Zou J, Liu C, Jiang S, Qian D, Duan J. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis. Infect Immun 2021;89:e0001421. [PMID: 33526559 DOI: 10.1128/IAI.00014-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Almási N, Török S, Dvorácskó S, Tömböly C, Csonka Á, Baráth Z, Murlasits Z, Valkusz Z, Pósa A, Varga C, Kupai K. Lessons on the Sigma-1 Receptor in TNBS-Induced Rat Colitis: Modulation of the UCHL-1, IL-6 Pathway. Int J Mol Sci 2020;21:E4046. [PMID: 32516975 DOI: 10.3390/ijms21114046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Besednova NN, Zaporozhets TS, Kuznetsova TA, Makarenkova ID, Kryzhanovsky SP, Fedyanina LN, Ermakova SP. Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine. Mar Drugs 2020;18:E289. [PMID: 32486405 DOI: 10.3390/md18060289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Nunes C, Freitas V, Almeida L, Laranjinha J. Red wine extract preserves tight junctions in intestinal epithelial cells under inflammatory conditions: implications for intestinal inflammation. Food Funct 2019;10:1364-74. [PMID: 30735221 DOI: 10.1039/c8fo02469c] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
13 Tamburini B, La Manna MP, La Barbera L, Mohammadnezhad L, Badami GD, Shekarkar Azgomi M, Dieli F, Caccamo N. Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease. Cells 2022;11:455. [DOI: 10.3390/cells11030455] [Reference Citation Analysis]
14 Kłos P, Dabravolski SA. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer. Int J Mol Sci 2021;22:11673. [PMID: 34769108 DOI: 10.3390/ijms222111673] [Reference Citation Analysis]
15 Tang X, Huang G, Zhang T, Li S. Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways. Biosci Biotechnol Biochem 2020;84:1903-12. [PMID: 32525764 DOI: 10.1080/09168451.2020.1776590] [Reference Citation Analysis]
16 Bastami M, Masotti A, Saadatian Z, Daraei A, Farjam M, Ghanbariasad A, Vahed SZ, Eyvazi S, Mansoori Y, Nariman-Saleh-Fam Z. Critical roles of microRNA-196 in normal physiology and non-malignant diseases: Diagnostic and therapeutic implications. Exp Mol Pathol 2021;122:104664. [PMID: 34166682 DOI: 10.1016/j.yexmp.2021.104664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liebert A, Wileńska A, Czuber-Dochan W, Kłopocka M. Translation and validation of the inflammatory bowel disease fatigue (IBD-F) patient self-assessment questionnaire. Prz Gastroenterol 2021;6:136-43. [PMID: 34276841 DOI: 10.5114/pg.2021.106665] [Reference Citation Analysis]
18 Long SR, Liu RD, Kumar DV, Wang ZQ, Su CW. Immune Protection of a Helminth Protein in the DSS-Induced Colitis Model in Mice. Front Immunol 2021;12:664998. [PMID: 33995396 DOI: 10.3389/fimmu.2021.664998] [Reference Citation Analysis]
19 Hong HS, Kim K, Oh K, Lee JY, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Park SH. Short-term tolerability and effectiveness of methotrexate monotherapy in adult patients with Crohn's disease: a retrospective study. Therap Adv Gastroenterol 2021;14:17562848211043017. [PMID: 34539814 DOI: 10.1177/17562848211043017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Pedersen SJ, Maksymowych WP. Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology. Drugs 2018;78:1397-418. [PMID: 30171593 DOI: 10.1007/s40265-018-0971-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Tavassolifar MJ, Changaei M, Salehi Z, Ghasemi F, Javidan M, Nicknam MH, Pourmand MR. Redox imbalance in Crohn's disease patients is modulated by Azathioprine. Redox Rep 2021;26:80-4. [PMID: 33882797 DOI: 10.1080/13510002.2021.1915665] [Reference Citation Analysis]
22 Kamali AN, Noorbakhsh SM, Hamedifar H, Jadidi-Niaragh F, Yazdani R, Bautista JM, Azizi G. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol Immunol 2019;105:107-15. [PMID: 30502718 DOI: 10.1016/j.molimm.2018.11.015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
23 Crooks B, Barnes T, Limdi JK. Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms. Drugs Context. 2020;9:2019-10. [PMID: 32180822 DOI: 10.7573/dic.2019-10-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Najeeb H, Yasmin F, Surani S. Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients. World J Clin Cases 2022; 10(14): 4327-4333 [DOI: 10.12998/wjcc.v10.i14.4327] [Reference Citation Analysis]
25 Li J, Mu Y, Liu Y, Kishimura A, Mori T, Katayama Y. Effect of Size and Loading of Retinoic Acid in Polyvinyl Butyrate Nanoparticles on Amelioration of Colitis. Polymers (Basel) 2021;13:1472. [PMID: 34063206 DOI: 10.3390/polym13091472] [Reference Citation Analysis]
26 Kilby K, Mathias H, Boisvenue L, Heisler C, Jones JL. Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review. Nutrients 2019;11:E1388. [PMID: 31226828 DOI: 10.3390/nu11061388] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
27 Lai H, Yang Z, Lou Z, Li F, Xie F, Pan W, Xu C, Zhang L, Zhang S, Zhang L, Huang M. Root Extract of Lindera aggregata (Sims) Kosterm. Modulates the Th17/Treg Balance to Attenuate DSS-Induced Colitis in Mice by IL-6/STAT3 Signaling Pathway. Front Pharmacol 2021;12:615506. [PMID: 34093175 DOI: 10.3389/fphar.2021.615506] [Reference Citation Analysis]
28 Emond B, Ellis LA, Chakravarty SD, Ladouceur M, Lefebvre P. Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors. Curr Med Res Opin 2019;35:1751-9. [PMID: 31106607 DOI: 10.1080/03007995.2019.1620713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
29 Ogundepo S, Chiamaka AM, Olatinwo M, Adepoju D, Aladesanmi MT, Celestine UO, Ali KC, Umezinwa OJ, Olasore J, Alausa A. The role of diosgenin in crohn’s disease. Clin Phytosci 2022;8. [DOI: 10.1186/s40816-022-00338-z] [Reference Citation Analysis]
30 Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, Gasbarrini A, Franceschi F. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:6242. [PMID: 34200555 DOI: 10.3390/ijms22126242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Park I, Jung J, Lee S, Park K, Ryu JW, Son MY, Cho HS, Kim DS. Characterization of terminal-ileal and colonic Crohn's disease in treatment-naïve paediatric patients based on transcriptomic profile using logistic regression. J Transl Med 2021;19:250. [PMID: 34098982 DOI: 10.1186/s12967-021-02909-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Pierdomenico M, Palone F, Cesi V, Vitali R, Mancuso AB, Cucchiara S, Oliva S, Aloi M, Stronati L. Transcription Factor ZNF281: A Novel Player in Intestinal Inflammation and Fibrosis. Front Immunol 2018;9:2907. [PMID: 30619271 DOI: 10.3389/fimmu.2018.02907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Caparrós E, Wiest R, Scharl M, Rogler G, Gutiérrez Casbas A, Yilmaz B, Wawrzyniak M, Francés R. Dysbiotic microbiota interactions in Crohn's disease. Gut Microbes 2021;13:1949096. [PMID: 34313550 DOI: 10.1080/19490976.2021.1949096] [Reference Citation Analysis]
34 Yang M, Liu W, Deng Q, Liang Z, Wang Q. The incidence of psoriasis among smokers and/or former smokers inflammatory bowel diseases patients treated with tumor necrosis factor antagonist: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27510. [PMID: 34678884 DOI: 10.1097/MD.0000000000027510] [Reference Citation Analysis]
35 Hong HS, Jung J, Park SH, Kim HJ, Hwang SW, Yang DH, Byeon JS, Myung SJ, Yang SK, Ye BD. Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases. Korean J Intern Med 2021. [PMID: 34482682 DOI: 10.3904/kjim.2020.386] [Reference Citation Analysis]
36 Hwang YJ, Nam SJ, Chun W, Kim SI, Park SC, Kang CD, Lee SJ. Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model. PLoS One 2019;14:e0217642. [PMID: 31141554 DOI: 10.1371/journal.pone.0217642] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
37 Qaiyum Z, Lim M, Inman RD. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights. Semin Immunopathol 2021;43:173-92. [PMID: 33625549 DOI: 10.1007/s00281-021-00845-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Jung YS, Han M, Park S, Cheon JH. Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn's Disease. Gut Liver 2021;15:92-9. [PMID: 32839359 DOI: 10.5009/gnl19377] [Reference Citation Analysis]
39 Yong Y, Fang B, Huang Y, Li J, Yu T, Wu L, Hu C, Liu X, Yu Z, Ma X, Gooneratne R, Li S, Abd El-aty AM, Ju X. Tea Tree Oil Terpinen-4-ol Protects Gut Barrier Integrity by Upregulation of Tight Junction Proteins via the ERK1/2-Signaling Pathway. Front Nutr 2022;8:805612. [DOI: 10.3389/fnut.2021.805612] [Reference Citation Analysis]
40 Rahman MM, Afroz S, Arthur S, Sundaram U. Mast Cell Mediated Regulation of Small Intestinal Chloride Malabsorption in SAMP1/YitFc Mouse Model of Spontaneous Chronic Ileitis. Cells 2021;10:697. [PMID: 33801010 DOI: 10.3390/cells10030697] [Reference Citation Analysis]
41 Kumar V. Innate Lymphoid Cells and Adaptive Immune Cells Cross-Talk: A Secret Talk Revealed in Immune Homeostasis and Different Inflammatory Conditions. Int Rev Immunol 2021;40:217-51. [PMID: 33733998 DOI: 10.1080/08830185.2021.1895145] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Gamah M, Alahdal M, Zhang Y, Zhou Y, Ji Q, Yuan Z, Han Y, Shen X, Ren Y, Zhang W. High-altitude hypoxia exacerbates dextran sulfate sodium (DSS)-induced colitis by upregulating Th1 and Th17 lymphocytes. Bioengineered 2021;12:7985-94. [PMID: 34666625 DOI: 10.1080/21655979.2021.1975017] [Reference Citation Analysis]
43 Zhou C, Zhou H, Zhang F, Hao L, Guo J. Active Ingredients and Potential Mechanisms of the Gan Jiang-Huang Qin-Huang Lian-Ren Shen Decoction against Ulcerative Colitis: A Network Pharmacology and Molecular Docking-Based Study. Evid Based Complement Alternat Med 2021;2021:1925718. [PMID: 34539797 DOI: 10.1155/2021/1925718] [Reference Citation Analysis]
44 Sousa A, Bradshaw TD, Ribeiro D, Fernandes E, Freitas M. Pro-inflammatory effects of silver nanoparticles in the intestine. Arch Toxicol 2022. [PMID: 35296919 DOI: 10.1007/s00204-022-03270-w] [Reference Citation Analysis]
45 Park SB, Choi BI, Lee BJ, Kim NJ, Jeong YA, Joo MK, Kim HJ, Park JJ, Kim JS, Noh YS, Lee HJ. Intestinal Epithelial Deletion of Sphk1 Prevents Colitis-Associated Cancer Development by Inhibition of Epithelial STAT3 Activation. Dig Dis Sci 2020;65:2284-93. [PMID: 31776862 DOI: 10.1007/s10620-019-05971-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Sheta NM, Boshra SA. Fabrication and Evaluation of Celecoxib Oral Oleogel to Reduce the Inflammation of Ulcerative Colitis. AAPS PharmSciTech 2021;22:180. [PMID: 34129135 DOI: 10.1208/s12249-021-02042-6] [Reference Citation Analysis]
47 Ge L, Xu M, Brant SR, Liu S, Zhu C, Shang J, Zhao Q, Zhou F. Sestrin3 enhances macrophage-mediated generation of T helper 1 and T helper 17 cells in a mouse colitis model. Int Immunol 2020;32:421-32. [PMID: 32154559 DOI: 10.1093/intimm/dxaa016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
48 Liu H, Dasgupta S, Fu Y, Bailey B, Roy C, Lightcap E, Faustin B. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD. BMC Immunol. 2019;20:42. [PMID: 31718550 DOI: 10.1186/s12865-019-0322-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
49 Elmahdy MK, Antar SA, Elmahallawy EK, Abdo W, Hijazy HHA, Albrakati A, Khodir AE. A Novel Role of Dapagliflozin in Mitigation of Acetic Acid-Induced Ulcerative Colitis by Modulation of Monocyte Chemoattractant Protein 1 (MCP-1)/Nuclear Factor-Kappa B (NF-κB)/Interleukin-18 (IL-18). Biomedicines 2022;10:40. [DOI: 10.3390/biomedicines10010040] [Reference Citation Analysis]
50 de Paula-Silva M, Broering MF, Scharf P, da Rocha GHO, Farsky S, Lino-Dos-Santos-Franco A. Red light-emitting diode treatment improves tissue recovery in DSS-induced colitis in mice. J Photochem Photobiol B 2020;212:112018. [PMID: 32957067 DOI: 10.1016/j.jphotobiol.2020.112018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Kim JH, Shin CY, Jang SW, Kim DS, Lee W, Kim HG, Kim HR. Anti-inflammatory effects of DA-9601, an extract of Artemisia asiatica, on aceclofenac-induced acute enteritis. Korean J Physiol Pharmacol 2021;25:439-48. [PMID: 34448461 DOI: 10.4196/kjpp.2021.25.5.439] [Reference Citation Analysis]
52 Guo G, Shi W, Shi F, Gong W, Li F, Zhou G, She J. Anti-inflammatory effects of eriocitrin against the dextran sulfate sodium-induced experimental colitis in murine model. J Biochem Mol Toxicol 2019;33:e22400. [PMID: 31593355 DOI: 10.1002/jbt.22400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Tarris G, de Rougemont A, Charkaoui M, Michiels C, Martin L, Belliot G. Enteric Viruses and Inflammatory Bowel Disease. Viruses 2021;13:104. [PMID: 33451106 DOI: 10.3390/v13010104] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Alam MT, Amos GCA, Murphy ARJ, Murch S, Wellington EMH, Arasaradnam RP. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut Pathog 2020;12:1. [PMID: 31911822 DOI: 10.1186/s13099-019-0341-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 32.5] [Reference Citation Analysis]
55 Soh H, Im JP, Han K, Park S, Hong SW, Moon JM, Kang EA, Chun J, Lee HJ, Kim JS. Crohn's disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study. Aliment Pharmacol Ther. 2020;51:446-456. [PMID: 31691306 DOI: 10.1111/apt.15562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
56 Negi S, Saini S, Tandel N, Sahu K, Mishra RPN, Tyagi RK. Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice. Cells 2021;10:1847. [PMID: 34440615 DOI: 10.3390/cells10081847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wu XX, Huang XL, Chen RR, Li T, Ye HJ, Xie W, Huang ZM, Cao GZ. Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers. Inflammation 2019;42:2215-25. [PMID: 31473900 DOI: 10.1007/s10753-019-01085-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
58 Song Y, Zhao Y, Ma Y, Wang Z, Rong L, Wang B, Zhang N. Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease. Cytokine Growth Factor Rev 2021;60:61-75. [PMID: 33773897 DOI: 10.1016/j.cytogfr.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Watanabe J, Furukawa S, Yagi S, Shiraishi K, Hanayama M, Tange K, Hashimoto Y, Kitahata S, Mori K, Ninomiya T, Suzuki S, Shibata N, Murakami H, Ohashi K, Hasebe A, Tomida H, Yamamoto Y, Takeshita E, Ikeda Y, Hiasa Y. Time spent per day in strenuous activity and total physical activity are inversely associated with mucosal healing but not with clinical remission in patients with ulcerative colitis. Ann Gastroenterol 2021;34:796-801. [PMID: 34815645 DOI: 10.20524/aog.2021.0663] [Reference Citation Analysis]
60 Lin SR, Chang CH, Tsai MJ, Cheng H, Chen JC, Leong MK, Weng CF. The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo. Ther Adv Chronic Dis 2019;10:2040622319875305. [PMID: 31555430 DOI: 10.1177/2040622319875305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
61 Nakkala JR, Li Z, Ahmad W, Wang K, Gao C. Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases. Acta Biomater 2021;123:1-30. [PMID: 33484912 DOI: 10.1016/j.actbio.2021.01.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
62 Altemus J, Dadgar N, Li Y, Lightner AL. Adipose tissue-derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease. J Cell Physiol 2022. [PMID: 35522572 DOI: 10.1002/jcp.30756] [Reference Citation Analysis]
63 Papadimitriou K. Effect of resistance exercise training on Crohn's disease patients. Intest Res 2021;19:275-81. [PMID: 33207853 DOI: 10.5217/ir.2020.00043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Jung YS, Han M, Park S, Cheon JH. Impact of early anti-TNF use on clinical outcomes in Crohn's disease: a nationwide population-based study. Korean J Intern Med 2020;35:1104-13. [PMID: 32306709 DOI: 10.3904/kjim.2020.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Rodríguez-Álvarez Y, Batista-Roche LG, Llopiz-Arzuaga A, Puente-Pérez P, Martínez-Castillo R, Castro-Velazco J, Santos-Savio A. Immunogenicity profile in African green monkeys of a vaccine candidate based on a mutated form of human Interleukin-15. BMC Immunol 2021;22:79. [PMID: 34922462 DOI: 10.1186/s12865-021-00470-4] [Reference Citation Analysis]
66 Ranasinghe R, Eri R. Pleiotropic Immune Functions of Chemokine Receptor 6 in Health and Disease. Medicines (Basel) 2018;5:E69. [PMID: 30004409 DOI: 10.3390/medicines5030069] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
67 Hwang J, Jin J, Jeon S, Moon SH, Park MY, Yum DY, Kim JH, Kang JE, Park MH, Kim EJ, Pan JG, Kwon O, Oh GT. SOD1 suppresses pro-inflammatory immune responses by protecting against oxidative stress in colitis. Redox Biol 2020;37:101760. [PMID: 33096425 DOI: 10.1016/j.redox.2020.101760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
68 Mecocci S, Ottaviani A, Razzuoli E, Fiorani P, Pietrucci D, De Ciucis CG, Dei Giudici S, Franzoni G, Chillemi G, Cappelli K. Cow Milk Extracellular Vesicle Effects on an In Vitro Model of Intestinal Inflammation. Biomedicines 2022;10:570. [DOI: 10.3390/biomedicines10030570] [Reference Citation Analysis]
69 Nourbakhsh E, Mohammadi A, Salemizadeh Parizi M, Mansouri A, Ebrahimzadeh F. Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target. Inflammopharmacology 2021. [PMID: 34283371 DOI: 10.1007/s10787-021-00846-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Kim JM, Kim DH, Park HJ, Ma HW, Park IS, Son M, Ro SY, Hong S, Han HK, Lim SJ, Kim SW, Cheon JH. Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model. J Nanobiotechnology 2020;18:133. [PMID: 32933548 DOI: 10.1186/s12951-020-00693-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
71 Chimenti MS, Conigliaro P, Biancone L, Perricone R. Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib. Ther Adv Musculoskelet Dis 2021;13:1759720X20977777. [PMID: 33680096 DOI: 10.1177/1759720X20977777] [Reference Citation Analysis]
72 Davis SP, Ross MSH, Adatorwovor R, Wei H. Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review. Res Nurs Health 2021;44:155-72. [DOI: 10.1002/nur.22091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Kandati K, Belagal P, Nannepaga JS, Viswanath B. Role of probiotics in the management of cervical cancer: An update. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.02.017] [Reference Citation Analysis]
74 Otagiri S, Ohnishi S, Ohara M, Fu Q, Yamamoto K, Yamamoto K, Katsurada T, Sakamoto N. Oleoylethanolamide Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats. Front Pharmacol 2020;11:1277. [PMID: 32922296 DOI: 10.3389/fphar.2020.01277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019;8. [PMID: 31835680 DOI: 10.3390/cells8121605] [Cited by in Crossref: 105] [Cited by in F6Publishing: 113] [Article Influence: 35.0] [Reference Citation Analysis]
76 Ren TH, Lv MM, An XM, Leung WK, Seto WK. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling. J Dig Dis 2020;21:38-45. [PMID: 31714673 DOI: 10.1111/1751-2980.12831] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
77 Dong S, Chen M, Dai F, Xuan Q, Chen P, Feng D, Gao L, Zhu C, Chang Y, Chu F, Gao Q. 5‐Hydroxytryptamine (5‐HT)‐exacerbated DSS‐induced colitis is associated with elevated NADPH oxidase expression in the colon. J Cell Biochem 2019;120:9230-42. [DOI: 10.1002/jcb.28198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
78 Raman M, Ghosh S. Diet and Nutrition in IBD-Progress and Gaps. Nutrients 2019;11:E1740. [PMID: 31357648 DOI: 10.3390/nu11081740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Wan M, Ding L, Wang D, Han J, Gao P. Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases. Front Immunol 2020;11:186. [PMID: 32117308 DOI: 10.3389/fimmu.2020.00186] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
80 Shankar J. Food Habit Associated Mycobiota Composition and Their Impact on Human Health. Front Nutr 2021;8:773577. [PMID: 34881282 DOI: 10.3389/fnut.2021.773577] [Reference Citation Analysis]
81 Gioxari A, Amerikanou C, Papada E, Zioga E, Georgoulis AD, Bamias G, Kaliora AC. Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases. Nutrients 2020;12:E3734. [PMID: 33291539 DOI: 10.3390/nu12123734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
82 Subramanya SB, Chandran S, Almarzooqi S, Raj V, Al Zahmi AS, Al Katheeri RA, Al Zadjali SA, Collin PD, Adrian TE. Frondanol, a Nutraceutical Extract from Cucumaria frondosa, Attenuates Colonic Inflammation in a DSS-Induced Colitis Model in Mice. Mar Drugs 2018;16:E148. [PMID: 29710854 DOI: 10.3390/md16050148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
83 Michetti F, Di Sante G, Clementi ME, Sampaolese B, Casalbore P, Volonté C, Romano Spica V, Parnigotto PP, Di Liddo R, Amadio S, Ria F. Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders. Neurosci Biobehav Rev 2021;127:446-58. [PMID: 33971224 DOI: 10.1016/j.neubiorev.2021.04.035] [Reference Citation Analysis]
84 Fan Y, Fan Y, Liu K, Lonan P, Liao F, Huo Y, Zhong X, Liang Y, Wang Y, Hou S, Lai X, Li G, Kuang W. Edible Bird's Nest Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in C57BL/6J Mice by Restoring the Th17/Treg Cell Balance. Front Pharmacol 2021;12:632602. [PMID: 33967768 DOI: 10.3389/fphar.2021.632602] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Raman M, Rajagopalan V, Kaur S, Reimer RA, Ma C, Ghosh S, Vallance J. Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review. Inflamm Bowel Dis 2021:izab218. [PMID: 34605548 DOI: 10.1093/ibd/izab218] [Reference Citation Analysis]
86 Kirk NV, Jensen JMB, Petersen MS, Al-Mousawi A, Mogensen TH, Christiansen M, Larsen CS. Very early onset inflammatory bowel disease with compound heterozygous variants in Nuclear Factor of Activated T cell 5. Eur J Immunol 2021;51:999-1001. [PMID: 33559909 DOI: 10.1002/eji.202048602] [Reference Citation Analysis]
87 Wang Y, Li C, Wang W, Wang J, Li J, Qian S, Cai C, Liu Y. Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease. JIR 2022;Volume 15:1907-20. [DOI: 10.2147/jir.s347161] [Reference Citation Analysis]
88 Luzardo-Ocampo I, Loarca-Piña G, Gonzalez de Mejia E. Gallic and butyric acids modulated NLRP3 inflammasome markers in a co-culture model of intestinal inflammation. Food Chem Toxicol 2020;146:111835. [PMID: 33130239 DOI: 10.1016/j.fct.2020.111835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
89 Luo Y, Kiriya M, Tanigawa K, Kawashima A, Nakamura Y, Ishii N, Suzuki K. Host-Related Laboratory Parameters for Leprosy Reactions. Front Med (Lausanne) 2021;8:694376. [PMID: 34746168 DOI: 10.3389/fmed.2021.694376] [Reference Citation Analysis]
90 Watanabe K, Umićević Mirkov M, de Leeuw CA, van den Heuvel MP, Posthuma D. Genetic mapping of cell type specificity for complex traits. Nat Commun 2019;10:3222. [PMID: 31324783 DOI: 10.1038/s41467-019-11181-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
91 Patel JI, Kumbhani M, Raval MM. Protective Effect of Nelumbo nucifera Plant on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Rats. Ann Natl Acad Med Sci. [DOI: 10.1055/s-0042-1743133] [Reference Citation Analysis]
92 Fonseca-Camarillo G, Furuzawa-Carballeda J, Razo-López N, Barreto-Zúñiga R, Martínez-Benítez B, Yamamoto-Furusho JK. Intestinal production of secreted protein acidic and rich in cysteine (SPARC) in patients with ulcerative colitis. Immunobiology 2021;226:152095. [PMID: 34000572 DOI: 10.1016/j.imbio.2021.152095] [Reference Citation Analysis]
93 Kim JE, Won H, Kim YH, Kim ER, Hong SN, Chang DK. Specificity of clinical decision support tools for vedolizumab and ustekinumab in biologically naïve patients with Crohn's disease. Scand J Gastroenterol 2021;:1-3. [PMID: 34967701 DOI: 10.1080/00365521.2021.2020332] [Reference Citation Analysis]
94 Luque-Campos N, Contreras-López RA, Jose Paredes-Martínez M, Torres MJ, Bahraoui S, Wei M, Espinoza F, Djouad F, Elizondo-Vega RJ, Luz-Crawford P. Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response. Front Immunol 2019;10:798. [PMID: 31040848 DOI: 10.3389/fimmu.2019.00798] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
95 Lopetuso LR, Corbi M, Scaldaferri F, Petito V, Graziani C, Castri F, Neri M, Gasbarrini A, Sgambato A, Papa A. Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment. Eur J Gastroenterol Hepatol 2020;32:1527-32. [PMID: 32976192 DOI: 10.1097/MEG.0000000000001933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Han M, Jung YS, Cheon JH, Park S. Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based Study. Yonsei Med J 2020;61:382-90. [PMID: 32390361 DOI: 10.3349/ymj.2020.61.5.382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Morshedzadeh N, Rahimlou M, Shahrokh S, Karimi S, Mirmiran P, Zali MR. The effects of flaxseed supplementation on metabolic syndrome parameters, insulin resistance and inflammation in ulcerative colitis patients: An open-labeled randomized controlled trial. Phytother Res 2021;35:3781-91. [PMID: 33856729 DOI: 10.1002/ptr.7081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Majidova K, Handfield J, Kafi K, Martin RD, Kubinski R. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review. Genes (Basel) 2021;12:1465. [PMID: 34680860 DOI: 10.3390/genes12101465] [Reference Citation Analysis]
99 Zhu Y, Liu S, Yan S, Wang J, Zhang L, Li X, Wen L, Wu J. Phenylethyl isothiocyanate induces oxidative damage of porcine kidney cells mediated by reactive oxygen species. J Biochem Mol Toxicol 2020;34:e22428. [PMID: 31860765 DOI: 10.1002/jbt.22428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
100 Gonzalez-pujana A, Beloqui A, Javier Aguirre J, Igartua M, Santos-vizcaino E, Maria Hernandez R. Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.01.007] [Reference Citation Analysis]
101 Wang JH, Liu XL, Sun JM, Yang JH, Xu DH, Yan SS. Role of mesenchymal stem cell derived extracellular vesicles in autoimmunity: A systematic review. World J Stem Cells 2020; 12(8): 879-896 [PMID: 32952864 DOI: 10.4252/wjsc.v12.i8.879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
102 Ranasinghe R, Eri R. CCR6–CCL20-Mediated Immunologic Pathways in Inflammatory Bowel Disease. GastrointestDisord 2018;1:15-29. [DOI: 10.3390/gidisord1010003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Fonseca-Camarillo G, Furuzawa-Carballeda J, Priego-Ranero ÁA, Zúñiga RB, Martínez-Benítez B, Yamamoto-Furusho JK. AKAP12/Gravin is over-expressed in patients with ulcerative colitis. Immunol Res 2021. [PMID: 34327631 DOI: 10.1007/s12026-021-09214-3] [Reference Citation Analysis]
104 Pippis EJ, Yacyshyn BR. Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD. Inflamm Bowel Dis 2021;27:1674-83. [PMID: 33295611 DOI: 10.1093/ibd/izaa318] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Furukawa S, Ikeda Y, Yagi S, Miyake T, Shiraishi K, Tange K, Hashimoto Y, Mori K, Ninomiya T, Suzuki S, Shibata N, Murakami H, Ohashi K, Hasebe A, Tomida H, Yamamoto Y, Takeshita E, Hiasa Y. Association Between Peripheral Blood Monocyte Count and Mucosal Healing in Japanese Patients With Ulcerative Colitis. Clin Transl Gastroenterol 2021;12:e00429. [PMID: 34797817 DOI: 10.14309/ctg.0000000000000429] [Reference Citation Analysis]
106 Choi K, Chun J, Han K, Park S, Soh H, Kim J, Lee J, Lee HJ, Im JP, Kim JS. Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study. J Clin Med. 2019;8. [PMID: 31083476 DOI: 10.3390/jcm8050654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
107 Mirlekar B. Co-expression of master transcription factors determines CD4+ T cell plasticity and functions in auto-inflammatory diseases. Immunol Lett 2020;222:58-66. [PMID: 32220615 DOI: 10.1016/j.imlet.2020.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
108 Meng Q, Wu W, Pei T, Xue J, Xiao P, Sun L, Li L, Liang D. miRNA-129/FBW7/NF-κB, a Novel Regulatory Pathway in Inflammatory Bowel Disease. Mol Ther Nucleic Acids 2020;19:731-40. [PMID: 31945730 DOI: 10.1016/j.omtn.2019.10.048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
109 Ren Q, Sun S, Zhang X. Redox-active nanoparticles for inflammatory bowel disease. Nano Res 2021;14:2535-57. [DOI: 10.1007/s12274-021-3303-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Zhang H, Zhang F, Li W. Function of intestinal barrier protected by regulating the miR-199a-3p in ulcerative colitis: Modulation of IL-23/IL-17A axis. Fundam Clin Pharmacol 2021;35:852-60. [PMID: 33475196 DOI: 10.1111/fcp.12650] [Reference Citation Analysis]
111 Hu T, Hu W, Ma L, Zeng X, Liu J, Cheng B, Yang P, Qiu S, Yang G, Chen D, Liu Z. pVAX1-A20 alleviates colitis in mice by promoting regulatory T cells. Dig Liver Dis 2019;51:790-7. [PMID: 30528569 DOI: 10.1016/j.dld.2018.11.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
112 Noel DD, Marinella P, Mauro G, Tripodi SI, Pin A, Serena A, Matteo B, Giuseppe FM, Patrizia A, Stefano C, Tommasini A, Raffaele B. Genetic Variants Assessing Crohn's Disease Pattern in Pediatric Inflammatory Bowel Disease Patients by a Clinical Exome Survey. Bioinform Biol Insights 2021;15:11779322211055285. [PMID: 35002226 DOI: 10.1177/11779322211055285] [Reference Citation Analysis]
113 Cartron A, Driscoll MS. Comorbidities of hidradenitis suppurativa: A review of the literature. Int J Womens Dermatol 2019;5:330-4. [PMID: 31909152 DOI: 10.1016/j.ijwd.2019.06.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
114 Long Y, Wang C, Xia C, Li X, Fan C, Zhao X, Liu C. Recovery of CD226-TIGIT+FoxP3+ and CD226-TIGIT-FoxP3+ regulatory T cells contributes to clinical remission from active stage in ulcerative colitis patients. Immunol Lett 2020;218:30-9. [PMID: 31883787 DOI: 10.1016/j.imlet.2019.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
115 Ala M, Kheyri Z. The rationale for selenium supplementation in inflammatory bowel disease: A mechanism-based point of view. Nutrition 2021;85:111153. [PMID: 33578241 DOI: 10.1016/j.nut.2021.111153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
116 Craig CF, Filippone RT, Stavely R, Bornstein JC, Apostolopoulos V, Nurgali K. Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease. J Neuroinflammation 2022;19:4. [PMID: 34983592 DOI: 10.1186/s12974-021-02354-1] [Reference Citation Analysis]
117 Hanić M, Trbojević-Akmačić I, Lauc G. Inflammatory bowel disease - glycomics perspective. Biochim Biophys Acta Gen Subj 2019;1863:1595-601. [PMID: 31276732 DOI: 10.1016/j.bbagen.2019.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
118 Zhou Y, Dou F, Song H, Liu T. Anti‐ulcerative effects of wogonin on ulcerative colitis induced by dextran sulfate sodium via Nrf2/ TLR4 / NF‐κB signaling pathway in BALB /c mice. Environmental Toxicology. [DOI: 10.1002/tox.23457] [Reference Citation Analysis]
119 Kaur H, Gupta T, Kapila S, Kapila R. Protective effects of potential probiotic Lactobacillus rhamnosus (MTCC-5897) fermented whey on reinforcement of intestinal epithelial barrier function in a colitis-induced murine model. Food Funct 2021;12:6102-16. [PMID: 34047732 DOI: 10.1039/d0fo02641g] [Reference Citation Analysis]
120 T Virtanen A, Haikarainen T, Raivola J, Silvennoinen O. Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases. BioDrugs 2019;33:15-32. [PMID: 30701418 DOI: 10.1007/s40259-019-00333-w] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 25.3] [Reference Citation Analysis]
121 Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR, Yang SH. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci 2021;22:2719. [PMID: 33800290 DOI: 10.3390/ijms22052719] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
122 Sorini C, Cardoso RF, Gagliani N, Villablanca EJ. Commensal Bacteria-Specific CD4+ T Cell Responses in Health and Disease. Front Immunol 2018;9:2667. [PMID: 30524431 DOI: 10.3389/fimmu.2018.02667] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
123 Shiraishi K, Furukawa S, Yagi S, Mori K, Ninomiya T, Kawasaki K, Mizukami Y, Suzuki S, Uraoka M, Shibata N, Nakamura S, Imamine S, Murakami H, Ohashi K, Torisu M, Yano M, Hasebe A, Yano H, Murakami M, Takeshita E, Ikeda Y, Hiasa Y. Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis. Dig Dis Sci 2021. [PMID: 33537920 DOI: 10.1007/s10620-021-06834-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Suri K, Bubier JA, Wiles MV, Shultz LD, Amiji MM, Hosur V. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021;10:2204. [PMID: 34571853 DOI: 10.3390/cells10092204] [Reference Citation Analysis]
125 Park S, Kim J, Chun J, Han K, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson's Disease: A South Korean Nationwide Population-Based Study. J Clin Med. 2019;8. [PMID: 31398905 DOI: 10.3390/jcm8081191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
126 Kim J, Im JP, Yim JJ, Lee CK, Park DI, Eun CS, Jung SA, Shin JE, Lee KM, Cheon JH. Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy. Korean J Gastroenterol 2020;75:29-38. [PMID: 31986571 DOI: 10.4166/kjg.2020.75.1.29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Jung YS. Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea. Gut Liver 2020;14:3-4. [PMID: 31945814 DOI: 10.5009/gnl19374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Biagioli M, Marchianò S, Carino A, Di Giorgio C, Santucci L, Distrutti E, Fiorucci S. Bile Acids Activated Receptors in Inflammatory Bowel Disease. Cells 2021;10:1281. [PMID: 34064187 DOI: 10.3390/cells10061281] [Reference Citation Analysis]
129 Joo H, Oh MK, Kang JY, Park HS, Chae DH, Kim J, Lee JH, Yoo HM, Choi U, Kim DK, Lee H, Kim S, Yu KR. Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties. Biomedicines 2021;9:209. [PMID: 33670708 DOI: 10.3390/biomedicines9020209] [Reference Citation Analysis]
130 Monteiro CEDS, Filho HBDC, Silva FGO, de Souza MFF, Sousa JAO, Franco ÁX, Resende ÂC, de Moura RS, de Souza MHL, Soares PMG, Barbosa ALDR. Euterpe oleracea Mart. (Açaí) attenuates experimental colitis in rats: involvement of TLR4/COX-2/NF-ĸB. Inflammopharmacology 2021;29:193-204. [PMID: 32996043 DOI: 10.1007/s10787-020-00763-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Danese S, Levesque BG, Feagan BG, Jucov A, Bhandari BR, Pai RK, Taylor Meadows K, Kirby BJ, Bruey JM, Olson A, Osterhout R, Van Biene C, Ford J, Aranda R, Raghupathi K, Sandborn WJ. Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis. Aliment Pharmacol Ther 2022. [PMID: 35014040 DOI: 10.1111/apt.16753] [Reference Citation Analysis]
132 Fiorucci S, Carino A, Baldoni M, Santucci L, Costanzi E, Graziosi L, Distrutti E, Biagioli M. Bile Acid Signaling in Inflammatory Bowel Diseases. Dig Dis Sci 2021;66:674-93. [PMID: 33289902 DOI: 10.1007/s10620-020-06715-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
133 Bermick J, Schaller M. Epigenetic regulation of pediatric and neonatal immune responses. Pediatr Res 2021. [PMID: 34239066 DOI: 10.1038/s41390-021-01630-3] [Reference Citation Analysis]
134 Niechcial A, Butter M, Manz S, Obialo N, Bäbler K, van der Lely L, Lang S, Gottier C, McCole DF, Scharl M, Spalinger MR. Presence of PTPN2 SNP rs1893217 Enhances the Anti-inflammatory Effect of Spermidine. Inflamm Bowel Dis 2020;26:1038-49. [PMID: 32031616 DOI: 10.1093/ibd/izaa013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
135 Nunes NS, Chandran P, Sundby M, Visioli F, da Costa Gonçalves F, Burks SR, Paz AH, Frank JA. Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway. EBioMedicine 2019;45:495-510. [PMID: 31253515 DOI: 10.1016/j.ebiom.2019.06.033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
136 Matsuoka K, Naganuma M, Hibi T, Tsubouchi H, Oketani K, Katsurabara T, Hojo S, Takenaka O, Kawano T, Imai T, Kanai T. Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease. J Gastroenterol Hepatol 2021;36:2180-6. [PMID: 33599356 DOI: 10.1111/jgh.15463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Han M, Jung YS, Cheon JH, Park S. Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study. Yonsei Med J 2020;61:48-55. [PMID: 31887799 DOI: 10.3349/ymj.2020.61.1.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
138 Dahiya DS, Perisetti A, Kichloo A, Singh A, Goyal H, Rotundo L, Vennikandam M, Shaka H, Singh G, Singh J, Pisipati S, Al-Haddad M, Sanaka MR, Inamdar S. Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma. World J Gastrointest Pathophysiol 2022; 13(3): 85-95 [DOI: 10.4291/wjgp.v13.i3.85] [Reference Citation Analysis]
139 Han M, Jung YS, Cheon JH, Park S. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases. J Gastroenterol Hepatol 2019;34:1166-74. [PMID: 30672608 DOI: 10.1111/jgh.14609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
140 Long Y, Zhao X, Xia C, Li X, Fan C, Liu C, Wang C. Upregulated IL‐17A secretion and CCR6 co‐expression in Treg subsets are related to the imbalance of Treg/Th17 cells in active UC patients. Scand J Immunol 2020;91. [DOI: 10.1111/sji.12842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
141 Miró L, Amat C, Rosell-Cardona C, Campbell JM, Polo J, Pérez-Bosque A, Moretó M. Dietary Supplementation with Spray-Dried Porcine Plasma Attenuates Colon Inflammation in a Genetic Mouse Model of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E6760. [PMID: 32942624 DOI: 10.3390/ijms21186760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
142 Kojima F, Sekiya H, Hioki Y, Kashiwagi H, Kubo M, Nakamura M, Maehana S, Imamichi Y, Yuhki KI, Ushikubi F, Kitasato H, Ichikawa T. Facilitation of colonic T cell immune responses is associated with an exacerbation of dextran sodium sulfate-induced colitis in mice lacking microsomal prostaglandin E synthase-1. Inflamm Regen 2022;42:1. [PMID: 34983695 DOI: 10.1186/s41232-021-00188-1] [Reference Citation Analysis]
143 Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
144 Chun J, Im JP, Kim JW, Lee KL, Choi CH, Kim H, Cheon JH, Ye BD, Kim YH, Kim YS, Jeen YT, Han DS, Kim WH, Kim JS. Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study. Gut Liver 2018;12:544-54. [PMID: 30037171 DOI: 10.5009/gnl18157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
145 Aximujiang K, Kaheman K, Wushouer X, Wu G, Ahemaiti A, Yunusi K. Lactobacillus acidophilus and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism. Front Pharmacol 2022;13:859628. [DOI: 10.3389/fphar.2022.859628] [Reference Citation Analysis]
146 Zhang Y, Jiang D, Jin Y, Jia H, Yang Y, Kim IH, Dai Z, Zhang J, Ren F, Wu Z. Glycine Attenuates Citrobacter rodentium-Induced Colitis by Regulating ATF6-Mediated Endoplasmic Reticulum Stress in Mice. Mol Nutr Food Res 2021;65:e2001065. [PMID: 34075695 DOI: 10.1002/mnfr.202001065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Liu M, Yuan W, Park S. Association between IL-10 rs3024505 and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis. Cytokine 2022;149:155721. [PMID: 34628128 DOI: 10.1016/j.cyto.2021.155721] [Reference Citation Analysis]
148 Sun L, Kong R, Li H, Wang D. The Role of T Follicular Helper Cells and Interleukin-21 in the Pathogenesis of Inflammatory Bowel Disease. Gastroenterol Res Pract 2021;2021:9621738. [PMID: 34471409 DOI: 10.1155/2021/9621738] [Reference Citation Analysis]
149 Jacob L, Koyanagi A, Smith L, Tanislav C, Konrad M, van der Beck S, Kostev K. Prevalence of, and factors associated with, long-term COVID-19 sick leave in working-age patients followed in general practices in Germany. Int J Infect Dis 2021;109:203-8. [PMID: 34224870 DOI: 10.1016/j.ijid.2021.06.063] [Reference Citation Analysis]
150 Choi MY, Ma C. Making a big impact with small datasets using machine-learning approaches. The Lancet Rheumatology 2020;2:e451-2. [DOI: 10.1016/s2665-9913(20)30217-4] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
151 Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. J Transl Med 2019;17:419. [PMID: 31836022 DOI: 10.1186/s12967-019-02174-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
152 Takač B, Mihaljević S, Glavaš-Obrovac L, Kibel A, Suver-Stević M, Canecki-Varžić S, Samardžija M, Rajkovac I, Kovač D, Štefanić M. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS. Acta Clin Croat 2020;59:67-80. [PMID: 32724277 DOI: 10.20471/acc.2020.59.01.09] [Reference Citation Analysis]
153 Park YE, Park SJ, Park JJ, Cheon JH, Kim T, Kim WH. Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet's disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin. BMC Gastroenterol 2021;21:32. [PMID: 33478396 DOI: 10.1186/s12876-021-01609-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Chen Y, Cui W, Li X, Yang H. Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease. Front Immunol 2021;12:761981. [PMID: 34858414 DOI: 10.3389/fimmu.2021.761981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Park S, Chun J, Han KD, Soh H, Choi K, Kim JH, Lee J, Lee C, Im JP, Kim JS. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2018; 24(42): 4798-4808 [PMID: 30479466 DOI: 10.3748/wjg.v24.i42.4798] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
156 Rana MN, Lu J, Xue E, Ruan J, Liu Y, Zhang L, Dhar R, Li Y, Hu Z, Zhou J, Ma W, Tang H. PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization. Front Pharmacol 2021;12:643215. [PMID: 33967779 DOI: 10.3389/fphar.2021.643215] [Reference Citation Analysis]
157 Boshtam M, Kouhpayeh S, Amini F, Azizi Y, Najaflu M, Shariati L, Khanahmad H. Anti-inflammatory effects of apocynin: a narrative review of the evidence. All Life 2021;14:997-1010. [DOI: 10.1080/26895293.2021.1990136] [Reference Citation Analysis]
158 Khashper A, Shwartz D, Taragin BH, Shalmon T. Splenic size as a marker for active inflammation in Crohn's disease. Clinical Imaging 2022. [DOI: 10.1016/j.clinimag.2022.02.012] [Reference Citation Analysis]
159 Ranasinghe R, Eri R. CCR6–CCL20 Axis in IBD: What Have We Learnt in the Last 20 Years? GastrointestDisord 2018;1:57-74. [DOI: 10.3390/gidisord1010006] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
160 Abbasi-Kenarsari H, Heidari N, Baghaei K, Amani D, Zali MR, Gaffari Khaligh S, Shafiee A, Hashemi SM. Synergistic therapeutic effect of mesenchymal stem cells and tolerogenic dendritic cells in an acute colitis mouse model. Int Immunopharmacol 2020;88:107006. [PMID: 33182049 DOI: 10.1016/j.intimp.2020.107006] [Reference Citation Analysis]
161 Mercier V, Boucher G, Devost D, Bourque K, Alikashani A, Beauchamp C, Bitton A, Foisy S, Goyette P, Charron G, Hébert TE, Rioux JD. IBD-associated G protein-coupled receptor 65 variant compromises signalling and impairs key functions involved in inflammation. Cell Signal 2022;:110294. [PMID: 35218908 DOI: 10.1016/j.cellsig.2022.110294] [Reference Citation Analysis]